Cancer Incidence and Response to the Crisis in Africa:@0.413688:0.035749:0.914587:0.035749:0.914587:0.019993:0.413688:0.019993:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.004349:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.011680:0.012508:0.007466:0.013123:0.012604:0.011738:0.007466:0.012508:0.005330:0.006523:0.012604:0.005330:0.006523:0.011738:0.012508:0.005330:0.015644:0.005792:0.003848:0.007466:0.003848:0.007466:0.005330:0.003848:0.011738:0.005330:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
5:@0.960791:0.038184:0.971327:0.038184:0.971327:0.018587:0.960791:0.018587:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
educational  drives  have  greatly  assisted :@0.084848:0.096166:0.481069:0.096166:0.481069:0.080410:0.084848:0.080410:0.012315:0.012989:0.011507:0.012257:0.012950:0.006331:0.003656:0.012411:0.011545:0.012950:0.003656:0.005330:0.005879:0.012989:0.005600:0.003656:0.010468:0.012315:0.007274:0.005330:0.005879:0.011545:0.012950:0.010468:0.012315:0.005330:0.005879:0.012758:0.005521:0.012315:0.012950:0.006331:0.003656:0.010122:0.005330:0.005879:0.012950:0.007274:0.007274:0.003656:0.007274:0.006331:0.012315:0.013183:0.005330
with acceptance. The practical difficulties :@0.084848:0.112583:0.481090:0.112583:0.481090:0.096827:0.084848:0.096827:0.015798:0.003656:0.006331:0.011545:0.006754:0.012950:0.012257:0.012257:0.012315:0.012931:0.006331:0.012950:0.011545:0.012257:0.012315:0.005138:0.006754:0.008005:0.011545:0.012315:0.006754:0.012931:0.005600:0.012950:0.012257:0.006331:0.003656:0.012257:0.012950:0.003656:0.006754:0.012989:0.003656:0.005850:0.004589:0.004589:0.012257:0.011507:0.003656:0.006331:0.003656:0.012315:0.007468:0.005330
of the absence of integrated school vac-:@0.084848:0.129000:0.475777:0.129000:0.475777:0.113244:0.084848:0.113244:0.012411:0.005850:0.007370:0.006331:0.011545:0.012315:0.007370:0.012950:0.012931:0.007274:0.012315:0.011545:0.012257:0.012315:0.007370:0.012411:0.005850:0.007370:0.003656:0.011545:0.006331:0.012315:0.012758:0.005600:0.012950:0.006331:0.012315:0.012989:0.007370:0.007274:0.012257:0.011545:0.012411:0.012411:0.003656:0.007370:0.010468:0.012950:0.012257:0.006388
cination programmes, the obtaining of pa-:@0.084848:0.145418:0.475814:0.145418:0.475814:0.129662:0.084848:0.129662:0.012257:0.003656:0.011545:0.012950:0.006331:0.003656:0.012411:0.011545:0.005099:0.012931:0.005521:0.012411:0.012758:0.005600:0.012950:0.017857:0.017857:0.012315:0.007274:0.005138:0.005099:0.006331:0.011545:0.012315:0.005099:0.012411:0.012931:0.006331:0.012950:0.003656:0.011545:0.003656:0.011545:0.012758:0.005099:0.012411:0.005850:0.005099:0.012931:0.012950:0.006388
rental consent and lack of immediate ben-:@0.084848:0.161835:0.475737:0.161835:0.475737:0.146079:0.084848:0.146079:0.005521:0.012315:0.011545:0.006331:0.012950:0.003656:0.004618:0.012257:0.012411:0.011545:0.007274:0.012315:0.011545:0.006331:0.004618:0.012950:0.011545:0.012989:0.004618:0.003656:0.012950:0.012257:0.009467:0.004618:0.012411:0.005850:0.004618:0.003656:0.017857:0.017857:0.012315:0.012989:0.003656:0.012950:0.006331:0.012315:0.004618:0.012931:0.012315:0.011545:0.006388
efit  have  hampered  roll-out  programmes :@0.084848:0.178253:0.481109:0.178253:0.481109:0.162497:0.084848:0.162497:0.012315:0.004589:0.004589:0.006331:0.005330:0.004181:0.011545:0.012950:0.010468:0.012315:0.005330:0.004181:0.011545:0.012950:0.017857:0.012931:0.012315:0.005521:0.012315:0.012989:0.005330:0.004181:0.005521:0.012411:0.003656:0.003656:0.006196:0.012411:0.011507:0.006331:0.005330:0.004181:0.012931:0.005521:0.012411:0.012758:0.005600:0.012950:0.017857:0.017857:0.012315:0.007470:0.005330
across the continent in both low- and mid-:@0.084848:0.194670:0.475792:0.194670:0.475792:0.178914:0.084848:0.178914:0.012950:0.012257:0.005519:0.012411:0.007274:0.007274:0.005753:0.006331:0.011545:0.012315:0.005753:0.012257:0.012411:0.011545:0.006331:0.003656:0.011545:0.012315:0.011545:0.006331:0.005753:0.003656:0.011545:0.005753:0.012931:0.012411:0.006331:0.011545:0.005753:0.003656:0.012411:0.015798:0.006196:0.005753:0.012950:0.011545:0.012989:0.005753:0.017857:0.003656:0.012989:0.006388
dle-income countries.:@0.084848:0.211087:0.283411:0.211087:0.283411:0.195331:0.084848:0.195331:0.012989:0.003656:0.012315:0.006196:0.003656:0.011545:0.012257:0.012411:0.017857:0.012315:0.005138:0.012257:0.012411:0.011507:0.011545:0.006331:0.005600:0.003656:0.012315:0.007274:0.005330
The reduction of tobacco consumption :@0.103032:0.227505:0.481103:0.227505:0.481103:0.211749:0.103032:0.211749:0.008197:0.011738:0.012508:0.006660:0.005713:0.012508:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.006662:0.012604:0.006042:0.006667:0.006523:0.012604:0.013123:0.013143:0.012450:0.012450:0.012604:0.006660:0.012450:0.012604:0.011738:0.007466:0.011699:0.018049:0.013123:0.006523:0.003848:0.012604:0.011738:0.005330
is without a doubt the most urgent public :@0.084848:0.243922:0.481069:0.243922:0.481069:0.228166:0.084848:0.228166:0.003848:0.007466:0.006523:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.006512:0.013143:0.006523:0.013181:0.012604:0.011699:0.013123:0.006523:0.006523:0.006523:0.011738:0.012508:0.006523:0.018049:0.012604:0.007466:0.006523:0.006523:0.011699:0.005804:0.012950:0.012508:0.011738:0.006523:0.006523:0.013123:0.011699:0.013123:0.003848:0.003848:0.012450:0.005330
health intervention  needed  on the  con-:@0.084848:0.260340:0.475781:0.260340:0.475781:0.244584:0.084848:0.244584:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.009506:0.003848:0.011738:0.006523:0.012508:0.005792:0.010660:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005330:0.004160:0.011738:0.012508:0.012508:0.013181:0.012508:0.013181:0.005330:0.004166:0.012604:0.011738:0.009506:0.006523:0.011738:0.012508:0.005330:0.004166:0.012450:0.012604:0.011738:0.006388
tinent.  A study in Uganda  demonstrated :@0.084848:0.276757:0.481117:0.276757:0.481117:0.261001:0.084848:0.261001:0.006523:0.003848:0.011738:0.012508:0.011738:0.006523:0.005330:0.005330:0.003408:0.014239:0.008755:0.007466:0.006523:0.011699:0.013181:0.010314:0.008755:0.003848:0.011738:0.008755:0.012604:0.012950:0.013143:0.011738:0.013181:0.013143:0.005330:0.003414:0.013181:0.012508:0.018049:0.012604:0.011738:0.007466:0.006523:0.005792:0.013143:0.006523:0.012508:0.013181:0.005330
that the direct and indirect costs of tobac-:@0.084848:0.293174:0.475760:0.293174:0.475760:0.277418:0.084848:0.277418:0.006523:0.011738:0.013143:0.006523:0.004387:0.006523:0.011738:0.012508:0.004387:0.013181:0.003848:0.005717:0.012508:0.012450:0.006523:0.004387:0.013143:0.011738:0.013181:0.004395:0.003848:0.011738:0.013181:0.003848:0.005719:0.012508:0.012450:0.006523:0.004387:0.012450:0.012604:0.007466:0.006523:0.007466:0.004393:0.012604:0.006042:0.004389:0.006523:0.012604:0.013123:0.013143:0.012450:0.006388
co-related health issues translate to 2.3% of :@0.084848:0.309592:0.481078:0.309592:0.481078:0.293836:0.084848:0.293836:0.012450:0.012604:0.006388:0.005709:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.003675:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.003675:0.003848:0.007466:0.007466:0.011699:0.012508:0.007466:0.003691:0.006523:0.005792:0.013143:0.011738:0.007466:0.003848:0.013143:0.006523:0.012508:0.003675:0.006523:0.012604:0.003675:0.010660:0.005330:0.010660:0.014913:0.003675:0.012604:0.006042:0.005330
the total national expenditure on health.:@0.084848:0.326009:0.463341:0.326009:0.463341:0.310253:0.084848:0.310253:0.006523:0.011738:0.012508:0.005349:0.006523:0.012604:0.006523:0.013143:0.003848:0.005349:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005349:0.012508:0.009236:0.013123:0.012508:0.011738:0.013181:0.003848:0.006523:0.011699:0.005709:0.012508:0.005349:0.012604:0.011738:0.005349:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.005330
19 :@0.463323:0.320349:0.478860:0.320349:0.478860:0.311164:0.463323:0.311164:0.006215:0.006215:0.003107
These data are translatable to most coun-:@0.084848:0.342383:0.475758:0.342383:0.475758:0.326627:0.084848:0.326627:0.008197:0.011738:0.012508:0.007466:0.012508:0.005278:0.013181:0.013143:0.006523:0.013143:0.005292:0.013143:0.005715:0.012508:0.005292:0.006523:0.005792:0.013143:0.011738:0.007466:0.003848:0.013143:0.006523:0.013143:0.013123:0.003848:0.012508:0.005292:0.006523:0.012604:0.005292:0.018049:0.012604:0.007466:0.006523:0.005282:0.012450:0.012604:0.011699:0.011703:0.006388
tries on the continent. Taxes and revenues :@0.084848:0.358800:0.481117:0.358800:0.481117:0.343044:0.084848:0.343044:0.006523:0.005792:0.003848:0.012508:0.007466:0.005388:0.012604:0.011738:0.005372:0.006523:0.011738:0.012508:0.005374:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.012508:0.011738:0.006523:0.005330:0.005369:0.007199:0.013143:0.009236:0.012508:0.007466:0.005388:0.013143:0.011738:0.013181:0.005388:0.005713:0.012508:0.010660:0.012508:0.011738:0.011699:0.012508:0.007466:0.005330
are usually not diverted to health care to :@0.084848:0.375218:0.481074:0.375218:0.481074:0.359462:0.084848:0.359462:0.013143:0.005715:0.012508:0.006696:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.006714:0.011738:0.012604:0.006514:0.006696:0.013181:0.003848:0.010660:0.012508:0.005792:0.006523:0.012508:0.013181:0.006696:0.006523:0.012604:0.006696:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.006696:0.012450:0.013143:0.005713:0.012508:0.006696:0.006523:0.012604:0.005330
offset these costs, and will not cover the :@0.084848:0.391635:0.481103:0.391635:0.481103:0.375879:0.084848:0.375879:0.012604:0.006094:0.006042:0.007466:0.012508:0.006523:0.007986:0.006523:0.011738:0.012508:0.007466:0.012508:0.007974:0.012450:0.012604:0.007466:0.006523:0.007466:0.005330:0.007986:0.013143:0.011738:0.013181:0.007986:0.015990:0.003848:0.003848:0.003848:0.007986:0.011738:0.012604:0.006523:0.007972:0.012450:0.012604:0.010660:0.012508:0.005792:0.007974:0.006523:0.011738:0.012508:0.005330
full cost of the adverse effects. What is im-:@0.084848:0.408052:0.475767:0.408052:0.475767:0.392296:0.084848:0.392296:0.006042:0.011699:0.003848:0.003848:0.005426:0.012450:0.012604:0.007466:0.006523:0.005426:0.012604:0.006042:0.005417:0.006523:0.011738:0.012508:0.005413:0.013143:0.013181:0.010660:0.012508:0.005792:0.007466:0.012508:0.005426:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.005415:0.018473:0.011738:0.013143:0.006523:0.005417:0.003848:0.007466:0.005426:0.003848:0.018049:0.006388
portant to resolve is the conflict of interest :@0.084848:0.424470:0.481096:0.424470:0.481096:0.408714:0.084848:0.408714:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.005782:0.006523:0.012604:0.005788:0.005713:0.012508:0.007466:0.012604:0.003848:0.010660:0.012508:0.005800:0.003848:0.007466:0.005802:0.006523:0.011738:0.012508:0.005788:0.012450:0.012604:0.011738:0.004666:0.004666:0.003848:0.012450:0.006523:0.005790:0.012604:0.006042:0.005790:0.003848:0.011738:0.006523:0.012508:0.005709:0.012508:0.007466:0.006523:0.005330
between  government  and the  tobacco :@0.084848:0.440887:0.481107:0.440887:0.481107:0.425131:0.084848:0.425131:0.013123:0.012508:0.006523:0.015990:0.012508:0.012508:0.011738:0.005330:0.004376:0.012950:0.012604:0.010660:0.012508:0.006192:0.011738:0.018049:0.012508:0.011738:0.006523:0.005330:0.004374:0.013143:0.011738:0.013181:0.009717:0.006523:0.011738:0.012508:0.005330:0.004378:0.006523:0.012604:0.013123:0.013143:0.012450:0.012450:0.012604:0.005330
industry and the urgency for intervention :@0.084848:0.457304:0.481107:0.457304:0.481107:0.441549:0.084848:0.441549:0.003848:0.011738:0.013181:0.011699:0.007466:0.006523:0.005792:0.010314:0.007928:0.013143:0.011738:0.013181:0.007928:0.006523:0.011738:0.012508:0.007916:0.011699:0.005805:0.012950:0.012508:0.011738:0.012450:0.010314:0.007918:0.006042:0.012604:0.005792:0.007916:0.003848:0.011738:0.006523:0.012508:0.005792:0.010660:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005330
from the WHO and global health leaders :@0.084848:0.473722:0.481084:0.473722:0.481084:0.457966:0.084848:0.457966:0.006042:0.005711:0.012604:0.018049:0.007312:0.006523:0.011738:0.012508:0.007312:0.018473:0.013143:0.016722:0.007312:0.013143:0.011738:0.013181:0.007312:0.012950:0.003848:0.012604:0.013123:0.013143:0.003848:0.007312:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.007312:0.003848:0.012508:0.013143:0.013181:0.012508:0.005792:0.007466:0.005330
to reduce consumption and access.:@0.084848:0.490139:0.424061:0.490139:0.424061:0.474383:0.084848:0.474383:0.006523:0.012604:0.005330:0.005703:0.012508:0.013181:0.011699:0.012450:0.012508:0.005330:0.012450:0.012604:0.011738:0.007466:0.011699:0.018049:0.013123:0.006523:0.003848:0.012604:0.011738:0.005330:0.013143:0.011738:0.013181:0.005330:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.005330
20:@0.424043:0.484494:0.436473:0.484494:0.436473:0.475308:0.424043:0.475308:0.006215:0.006215
Secondary  preventative  measures,  in-:@0.103030:0.506528:0.475756:0.506528:0.475756:0.490772:0.103030:0.490772:0.009583:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.005330:0.006698:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.006706:0.018049:0.012508:0.013143:0.007466:0.011699:0.005715:0.012508:0.007466:0.005330:0.005330:0.006704:0.003848:0.011738:0.006388
cluding mammography  screening,  cervi-:@0.084846:0.522945:0.475763:0.522945:0.475763:0.507189:0.084846:0.507189:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.008794:0.018049:0.013143:0.018049:0.018049:0.012604:0.012950:0.005792:0.013143:0.013123:0.011738:0.010314:0.005330:0.003448:0.007466:0.012450:0.005715:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.005330:0.005330:0.003448:0.012450:0.012508:0.005792:0.010660:0.003848:0.006388
cal smears, HPV-testing and PSA-testing, :@0.084846:0.539362:0.481086:0.539362:0.481086:0.523606:0.084846:0.523606:0.012450:0.013143:0.003848:0.009794:0.007466:0.018049:0.012508:0.013143:0.005792:0.007466:0.005330:0.009794:0.013143:0.011392:0.013508:0.006388:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.012950:0.009794:0.013143:0.011738:0.013181:0.009794:0.011392:0.009583:0.014239:0.006388:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.012950:0.005330:0.005330
are all well established in terms of detect-:@0.084846:0.555780:0.475775:0.555780:0.475775:0.540024:0.084846:0.540024:0.013143:0.005715:0.012508:0.005992:0.013143:0.003848:0.003848:0.006004:0.015990:0.012508:0.003848:0.003848:0.006004:0.012508:0.007466:0.006523:0.013143:0.013123:0.003848:0.003848:0.007466:0.011738:0.012508:0.013181:0.006004:0.003848:0.011738:0.006004:0.006523:0.012508:0.006319:0.018049:0.007466:0.006004:0.012604:0.006042:0.005988:0.013181:0.012508:0.006523:0.012508:0.012450:0.006523:0.006388
ing early disease or precursors of disease, :@0.084846:0.572197:0.481088:0.572197:0.481088:0.556441:0.084846:0.556441:0.003848:0.011738:0.012950:0.006589:0.012508:0.013143:0.005792:0.003848:0.010314:0.006600:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.006600:0.012604:0.005792:0.006583:0.013123:0.005715:0.012508:0.012450:0.011699:0.005792:0.007466:0.012604:0.005778:0.007466:0.006600:0.012604:0.006042:0.006587:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330
but  lack  of  infrastructure  and  financial :@0.084846:0.588615:0.481076:0.588615:0.481076:0.572859:0.084846:0.572859:0.013123:0.011699:0.006523:0.005330:0.007379:0.003848:0.013143:0.012450:0.009660:0.005330:0.007379:0.012604:0.006042:0.005330:0.007376:0.003848:0.011738:0.006042:0.005792:0.013143:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.011699:0.005702:0.012508:0.005330:0.007379:0.013143:0.011738:0.013181:0.005330:0.007378:0.004686:0.004686:0.011738:0.013143:0.011738:0.012450:0.003848:0.013143:0.003848:0.005330
backing in struggling health-care systems :@0.084846:0.605032:0.481105:0.605032:0.481105:0.589276:0.084846:0.589276:0.013123:0.013143:0.012450:0.009660:0.003848:0.011738:0.012950:0.007293:0.003848:0.011738:0.007293:0.007466:0.006523:0.005792:0.011699:0.012950:0.012950:0.003848:0.003848:0.011738:0.012950:0.007293:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.006388:0.012450:0.013143:0.005715:0.012508:0.007293:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.007466:0.005330
limit their use in Africa.  Innovation with :@0.084846:0.621449:0.481113:0.621449:0.481113:0.605693:0.084846:0.605693:0.003848:0.003848:0.018049:0.003848:0.006523:0.011545:0.006523:0.011738:0.012508:0.003848:0.005792:0.011545:0.011699:0.007466:0.012508:0.011545:0.003848:0.011738:0.011545:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.005330:0.006204:0.004349:0.011738:0.011738:0.012604:0.010660:0.013143:0.006523:0.003848:0.012604:0.011738:0.011545:0.015990:0.003848:0.006523:0.011738:0.005330
cheap on-site HPV testing and encourag-:@0.084846:0.637867:0.475756:0.637867:0.475756:0.622111:0.084846:0.622111:0.012450:0.011738:0.012508:0.013143:0.013123:0.005992:0.012604:0.011738:0.006388:0.007466:0.003848:0.006523:0.012508:0.005988:0.013143:0.011392:0.013508:0.005992:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.012950:0.005988:0.013143:0.011738:0.013181:0.005992:0.012508:0.011738:0.012450:0.012604:0.011699:0.005792:0.013143:0.012939:0.006388
ing a culture of breast self-examination are :@0.084846:0.654284:0.481082:0.654284:0.481082:0.638528:0.084846:0.638528:0.003848:0.011738:0.012950:0.003945:0.013143:0.003945:0.012450:0.011699:0.003848:0.006523:0.011699:0.005709:0.012508:0.003945:0.012604:0.006042:0.003945:0.013123:0.005717:0.012508:0.013143:0.007466:0.006523:0.003945:0.007466:0.012508:0.003848:0.006042:0.006388:0.012508:0.009236:0.013143:0.018049:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.003945:0.013143:0.005715:0.012508:0.005330
some methods that have been success-:@0.084846:0.670702:0.475736:0.670702:0.475736:0.654946:0.084846:0.654946:0.007466:0.012604:0.018049:0.012508:0.008890:0.018049:0.012508:0.006523:0.011738:0.012604:0.013181:0.007466:0.008890:0.006523:0.011738:0.013143:0.006523:0.008890:0.011738:0.013143:0.010660:0.012508:0.008890:0.013123:0.012508:0.012508:0.011738:0.008890:0.007466:0.011699:0.012450:0.012450:0.012508:0.007466:0.007466:0.006388
fully adopted in Africa. In better resourced :@0.084846:0.687119:0.481093:0.687119:0.481093:0.671363:0.084846:0.671363:0.006042:0.011699:0.003848:0.003848:0.010314:0.004618:0.013143:0.013181:0.012604:0.013123:0.006523:0.012508:0.013181:0.004605:0.003848:0.011738:0.004605:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.004599:0.004349:0.011738:0.004603:0.013123:0.012508:0.006523:0.006523:0.012508:0.005792:0.004599:0.005713:0.012508:0.007466:0.012604:0.011699:0.005651:0.012450:0.012508:0.013181:0.005330
countries  such as South  Africa, a variety :@0.084846:0.703536:0.481109:0.703536:0.481109:0.687780:0.084846:0.687780:0.012450:0.012604:0.011699:0.011738:0.006523:0.005792:0.003848:0.012508:0.007466:0.005330:0.003562:0.007466:0.011699:0.012450:0.011738:0.008909:0.013143:0.007466:0.008909:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.003562:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.008909:0.013143:0.008909:0.010660:0.013143:0.005792:0.003848:0.012508:0.006523:0.010314:0.005330
of screening procedures are provided :@0.084846:0.719954:0.481072:0.719954:0.481072:0.704198:0.084846:0.704198:0.012604:0.006042:0.014547:0.007466:0.012450:0.005711:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.014547:0.013123:0.005715:0.012604:0.012450:0.012508:0.013181:0.011699:0.005705:0.012508:0.007466:0.014547:0.013143:0.005715:0.012508:0.014547:0.013123:0.005715:0.012604:0.010660:0.003848:0.013181:0.012508:0.013181:0.005330
without  co-payment  to  those  who  have :@0.084846:0.736371:0.481082:0.736371:0.481082:0.720615:0.084846:0.720615:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.005330:0.004027:0.012450:0.012604:0.006388:0.013123:0.013143:0.010314:0.018049:0.012508:0.011738:0.006523:0.005330:0.004029:0.006523:0.012604:0.005330:0.004027:0.006523:0.011738:0.012604:0.007466:0.012508:0.005330:0.004027:0.015990:0.011738:0.012604:0.005330:0.004031:0.011738:0.013143:0.010660:0.012508:0.005330
health  insurance.  In  the  public sector,  a :@0.084846:0.752788:0.481084:0.752788:0.481084:0.737033:0.084846:0.737033:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.005330:0.004162:0.003848:0.011738:0.007466:0.011699:0.005792:0.013143:0.011738:0.012450:0.012508:0.005330:0.005330:0.004158:0.004349:0.011738:0.005330:0.004166:0.006523:0.011738:0.012508:0.005330:0.004158:0.013123:0.011699:0.013123:0.003848:0.003848:0.012450:0.009506:0.007466:0.012508:0.012450:0.006523:0.012604:0.003762:0.005330:0.005330:0.004164:0.013143:0.005330
pap smear at ages 30, 40  and 50 years :@0.084846:0.769206:0.481040:0.769206:0.481040:0.753450:0.084846:0.753450:0.013123:0.013143:0.013123:0.009025:0.007466:0.018049:0.012508:0.013143:0.005792:0.009025:0.013143:0.006523:0.009025:0.013143:0.012950:0.012508:0.007466:0.009025:0.010660:0.010660:0.005330:0.009025:0.010660:0.010660:0.005330:0.003706:0.013143:0.011738:0.013181:0.009025:0.010660:0.010660:0.009025:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330
is freely available at local district clinics, :@0.084846:0.785623:0.481063:0.785623:0.481063:0.769867:0.084846:0.769867:0.003848:0.007466:0.009198:0.006042:0.005713:0.012508:0.012508:0.003848:0.010314:0.009198:0.013143:0.010660:0.013143:0.003848:0.003848:0.013160:0.013123:0.003848:0.012508:0.009198:0.013143:0.006523:0.009198:0.003848:0.012604:0.012450:0.013143:0.003848:0.009198:0.013181:0.003848:0.007466:0.006523:0.005792:0.003848:0.012450:0.006523:0.009198:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.007466:0.005330:0.005330
but access to routine PSA-screening and :@0.084846:0.802041:0.481090:0.802041:0.481090:0.786285:0.084846:0.786285:0.013123:0.011699:0.006523:0.007947:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.007959:0.006523:0.012604:0.007947:0.005713:0.012604:0.011699:0.006523:0.003848:0.011738:0.012508:0.007947:0.011392:0.009583:0.014239:0.006388:0.007466:0.012450:0.005709:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.007947:0.013143:0.011738:0.013181:0.005330
mammography is limited by logistical dif-:@0.084846:0.818458:0.475759:0.818458:0.475759:0.802702:0.084846:0.802702:0.018049:0.013143:0.018049:0.018049:0.012604:0.012950:0.005792:0.013143:0.013123:0.011738:0.010314:0.007470:0.003848:0.007466:0.007485:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.007485:0.013123:0.010314:0.007485:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.003848:0.012450:0.013143:0.003848:0.007485:0.013181:0.003848:0.006042:0.006388
ficulties and infrastructure availability.:@0.084846:0.834875:0.432154:0.834875:0.432154:0.819120:0.084846:0.819120:0.004686:0.004686:0.012450:0.011699:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.003848:0.011738:0.006042:0.005792:0.013143:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.011699:0.005698:0.012508:0.005330:0.013143:0.010660:0.013143:0.003848:0.003848:0.013143:0.013123:0.003848:0.003848:0.003848:0.006523:0.010314:0.005330
CONCLUSION:@0.084848:0.868293:0.240070:0.868293:0.240070:0.848696:0.084848:0.848696:0.018344:0.019756:0.017404:0.018344:0.010348:0.015052:0.012230:0.006585:0.019756:0.017404
With cancer cases projected to increa- :@0.084848:0.887000:0.481086:0.887000:0.481086:0.871244:0.084848:0.871244:0.018584:0.003848:0.006523:0.011738:0.010333:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.010333:0.012450:0.013143:0.007466:0.012508:0.007466:0.010333:0.013123:0.005717:0.012604:0.003906:0.012508:0.012450:0.006523:0.012508:0.013181:0.010333:0.006523:0.012604:0.010333:0.003848:0.011738:0.012450:0.005715:0.012508:0.013143:0.006388:0.005330
se twofold in the coming decades, it is im-:@0.084848:0.903418:0.475800:0.903418:0.475800:0.887662:0.084848:0.887662:0.007466:0.012508:0.005311:0.006523:0.015990:0.012604:0.006042:0.012604:0.003848:0.013181:0.005311:0.003848:0.011738:0.005311:0.006523:0.011738:0.012508:0.005301:0.012450:0.012604:0.018049:0.003848:0.011738:0.012950:0.005296:0.013181:0.012508:0.012450:0.013143:0.013181:0.012508:0.007466:0.005330:0.005301:0.003848:0.006523:0.005311:0.003848:0.007466:0.005311:0.003848:0.018049:0.006388
perative that there is a focus on preven-:@0.084848:0.919835:0.475762:0.919835:0.475762:0.904079:0.084848:0.904079:0.013123:0.012508:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.007745:0.006523:0.011738:0.013143:0.006523:0.007737:0.006523:0.011738:0.012508:0.005705:0.012508:0.007741:0.003848:0.007466:0.007755:0.013143:0.007745:0.006042:0.012604:0.012450:0.011699:0.007466:0.007739:0.012604:0.011738:0.007737:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006388
tion and health education to ensure that :@0.084848:0.936252:0.481082:0.936252:0.481082:0.920497:0.084848:0.920497:0.006523:0.003848:0.012604:0.011738:0.007043:0.013143:0.011738:0.013181:0.007043:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.007043:0.012508:0.013181:0.011699:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007043:0.006523:0.012604:0.007043:0.012508:0.011738:0.007466:0.011699:0.005709:0.012508:0.007043:0.006523:0.011738:0.013143:0.006523:0.005330
vaccination is available, early detection is :@0.524249:0.096174:0.920488:0.096174:0.920488:0.080418:0.524249:0.080418:0.010660:0.013143:0.012450:0.012450:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005215:0.003848:0.007466:0.005215:0.013143:0.010660:0.013143:0.003848:0.003848:0.013143:0.013123:0.003848:0.012508:0.005330:0.005215:0.012508:0.013143:0.005792:0.003848:0.010314:0.005215:0.013181:0.012508:0.006523:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005195:0.003848:0.007466:0.005330
possible and people have access to qual-:@0.524249:0.112578:0.915135:0.112578:0.915135:0.096822:0.524249:0.096822:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.005057:0.013143:0.011738:0.013181:0.005042:0.013123:0.012508:0.012604:0.013123:0.003848:0.012508:0.005042:0.011738:0.013143:0.010660:0.012508:0.005042:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.005042:0.006523:0.012604:0.005042:0.013123:0.011699:0.013143:0.003848:0.006388
ity oncological care.:@0.524249:0.128982:0.716819:0.128982:0.716819:0.113226:0.524249:0.113226:0.003848:0.006523:0.010314:0.005330:0.012604:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.012450:0.013143:0.005707:0.012508:0.005330
REFERENCES:@0.524249:0.158841:0.635085:0.158841:0.635085:0.142807:0.524249:0.142807:0.011161:0.010006:0.009236:0.010006:0.011161:0.010006:0.014239:0.015009:0.010006:0.010006
1.:@0.524242:0.175785:0.538456:0.175785:0.538456:0.161779:0.524242:0.161779:0.009476:0.004738
  Bray F, Jemal A, Grey N, :@0.560589:0.175785:0.765622:0.175785:0.765622:0.161779:0.560589:0.161779:0.004738:-0.004738:0.009818:0.005148:0.011682:0.009168:0.005593:0.006205:0.004738:0.005593:0.008244:0.011118:0.016044:0.011682:0.003421:0.005593:0.012657:0.004738:0.005583:0.014915:0.005080:0.011118:0.009168:0.005593:0.012657:0.004738:0.004738
et al:@0.766457:0.175785:0.804061:0.175785:0.804061:0.161779:0.766457:0.161779:0.011118:0.005798:0.005585:0.011682:0.003421
. Global can-:@0.804061:0.175785:0.915153:0.175785:0.915153:0.161779:0.804061:0.161779:0.004738:0.005593:0.014915:0.003421:0.011203:0.011665:0.011682:0.003421:0.005593:0.011067:0.011682:0.010434:0.005679
cer transitions according to the Human:@0.560589:0.190131:0.915172:0.190131:0.915172:0.176126:0.560589:0.176126:0.011067:0.011118:0.005148:0.010981:0.005798:0.005148:0.011682:0.010434:0.006636:0.003421:0.005798:0.003421:0.011203:0.010434:0.006636:0.010981:0.011682:0.011067:0.011067:0.011203:0.005039:0.011716:0.003421:0.010434:0.011511:0.010981:0.005798:0.011203:0.010981:0.005798:0.010434:0.011118:0.010981:0.011682:0.010399:0.016044:0.011682:0.010434
Development Index (2008-2030): a popu-:@0.560589:0.204477:0.915159:0.204477:0.915159:0.190472:0.560589:0.190472:0.012726:0.011118:0.009476:0.011118:0.003421:0.011203:0.011665:0.016044:0.011118:0.010434:0.005798:0.008484:0.003866:0.010434:0.011716:0.011118:0.008210:0.008484:0.006312:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.006312:0.004769:0.008484:0.011682:0.008484:0.011665:0.011203:0.011665:0.010399:0.005679
lation-based study. :@0.560589:0.218823:0.725047:0.218823:0.725047:0.204818:0.560589:0.204818:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.005679:0.011665:0.011682:0.006636:0.011118:0.011716:0.006808:0.006636:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
The Lancet Oncology:@0.727117:0.218823:0.910419:0.218823:0.910419:0.204818:0.727117:0.204818:0.007286:0.010434:0.011118:0.006796:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.006797:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
.:@0.910419:0.218823:0.915157:0.218823:0.915157:0.204818:0.910419:0.204818:0.004738
2012;13(8):790-801.:@0.560589:0.233170:0.716290:0.233170:0.716290:0.219165:0.560589:0.219165:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
2.:@0.524242:0.247516:0.538456:0.247516:0.538456:0.233511:0.524242:0.233511:0.009476:0.004738
  Ferlay J, Steliarova-Foucher  E, Lortet-:@0.560589:0.247516:0.915177:0.247516:0.915177:0.233511:0.560589:0.233511:0.004738:-0.004738:0.008296:0.011118:0.005148:0.003421:0.011682:0.009168:0.017874:0.008244:0.004738:0.017874:0.008518:0.005798:0.011118:0.003421:0.003421:0.011682:0.005080:0.011203:0.009476:0.011682:0.005679:0.008296:0.011203:0.010399:0.011067:0.010434:0.011108:0.005148:0.004738:0.013128:0.009168:0.004738:0.017874:0.007902:0.011203:0.005148:0.005798:0.011118:0.005798:0.005679
Tieulent J, :@0.560589:0.261862:0.651883:0.261862:0.651883:0.247857:0.560589:0.247857:0.007808:0.003421:0.011118:0.010399:0.003421:0.011118:0.010434:0.005798:0.010057:0.008244:0.004738:0.004738
et al:@0.657203:0.261862:0.699279:0.261862:0.699279:0.247857:0.657203:0.247857:0.011118:0.005798:0.010057:0.011682:0.003421
. Cancer  incidence and:@0.699279:0.261862:0.915162:0.261862:0.915162:0.247857:0.699279:0.247857:0.004738:0.010057:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.005311:0.003421:0.010434:0.011067:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118:0.010057:0.011682:0.010434:0.011716
mortality patterns in Europe: estimates for:@0.560589:0.276209:0.915136:0.276209:0.915136:0.262203:0.560589:0.262203:0.016044:0.011203:0.005148:0.005798:0.011682:0.003421:0.003421:0.005798:0.009168:0.007406:0.011665:0.011682:0.005798:0.005798:0.011118:0.005501:0.010434:0.006636:0.007406:0.003421:0.010434:0.007406:0.009168:0.010399:0.005078:0.011203:0.011665:0.011118:0.004738:0.007406:0.011118:0.006636:0.005798:0.003421:0.016044:0.011682:0.005798:0.011118:0.006636:0.007406:0.005371:0.011203:0.005148
40 countries  in 2012. :@0.560589:0.290555:0.741796:0.290555:0.741796:0.276550:0.560589:0.276550:0.009476:0.009476:0.008603:0.011067:0.011203:0.010399:0.010434:0.005798:0.005148:0.003421:0.011118:0.006636:0.004738:0.003852:0.003421:0.010434:0.008603:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
Eur  J Cancer:@0.745661:0.290555:0.859174:0.290555:0.859174:0.276550:0.745661:0.276550:0.009168:0.010399:0.005148:0.004738:0.003857:0.008244:0.008603:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. 2013;:@0.859174:0.290555:0.915157:0.290555:0.915157:0.276550:0.859174:0.276550:0.004738:0.008603:0.009476:0.009476:0.009476:0.009476:0.004738
49(6):1374-403.:@0.560589:0.304901:0.683124:0.304901:0.683124:0.290896:0.560589:0.290896:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
3.:@0.524242:0.319248:0.538456:0.319248:0.538456:0.305242:0.524242:0.305242:0.009476:0.004738
  Ferlay J, Shin H, Bray, F. Estimates of world-:@0.560589:0.319248:0.915184:0.319248:0.915184:0.305242:0.560589:0.305242:0.004738:-0.004738:0.008296:0.011118:0.005148:0.003421:0.011682:0.009168:0.005884:0.008244:0.004738:0.005884:0.008518:0.010434:0.003421:0.010434:0.005884:0.011682:0.004738:0.005884:0.009818:0.005148:0.011682:0.009168:0.004738:0.005884:0.006941:0.004738:0.005884:0.009168:0.006636:0.005798:0.003421:0.016044:0.011682:0.005798:0.011118:0.006636:0.005884:0.011203:0.005371:0.005875:0.014214:0.011203:0.005148:0.003421:0.011716:0.005679
wide burden  of  cancer  in  2008: GLOBO- :@0.560606:0.333594:0.919900:0.333594:0.919900:0.319589:0.560606:0.319589:0.014214:0.003421:0.011716:0.011118:0.008689:0.011665:0.010399:0.005044:0.011716:0.011118:0.010434:0.004738:0.003939:0.011203:0.005371:0.004738:0.003937:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.003936:0.003421:0.010434:0.004738:0.003943:0.009476:0.009476:0.009476:0.009476:0.004738:0.008689:0.014915:0.007902:0.014864:0.009818:0.014864:0.005679:0.004738
CAN 2008. :@0.560606:0.347940:0.651825:0.347940:0.651825:0.333935:0.560606:0.333935:0.013906:0.012657:0.012657:0.004610:0.009476:0.009476:0.009486:0.009476:0.004738:0.004738
International Journal of Cancer.:@0.651705:0.347940:0.915188:0.347940:0.915188:0.333935:0.651705:0.333935:0.003866:0.010434:0.005798:0.011118:0.005148:0.010423:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004618:0.008244:0.011203:0.010399:0.005148:0.010434:0.011682:0.003421:0.004618:0.011203:0.005371:0.004618:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
2010;127(12):2893-2917.:@0.560606:0.362286:0.754210:0.362286:0.754210:0.348281:0.560606:0.348281:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
4.:@0.524259:0.376633:0.538473:0.376633:0.538473:0.362627:0.524259:0.362627:0.009476:0.004738
  GBD 2015 Disease and  Injury  Incidence:@0.560589:0.376633:0.915148:0.376633:0.915148:0.362627:0.560589:0.362627:0.004738:-0.004738:0.014915:0.009818:0.012726:0.011067:0.009476:0.009476:0.009476:0.009476:0.011067:0.012726:0.003421:0.006636:0.011118:0.011682:0.006636:0.011118:0.011067:0.011682:0.010434:0.011716:0.004738:0.006312:0.003866:0.010434:0.003472:0.010399:0.005148:0.009168:0.004738:0.006315:0.003866:0.010434:0.011067:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118
and Prevalence Collaborators, Vos T, Al-:@0.560589:0.390979:0.915152:0.390979:0.915152:0.376974:0.560589:0.376974:0.011682:0.010434:0.011716:0.009818:0.010126:0.005075:0.011118:0.009476:0.011682:0.003421:0.011118:0.010434:0.011067:0.011118:0.009818:0.013906:0.011203:0.003421:0.003421:0.011682:0.011665:0.011203:0.005148:0.011682:0.005798:0.011203:0.005148:0.006636:0.004738:0.009818:0.010280:0.011203:0.006636:0.009818:0.005537:0.004738:0.009818:0.012657:0.003421:0.005679
len C, Arora M, :@0.560589:0.405325:0.690352:0.405325:0.690352:0.391320:0.560589:0.391320:0.003421:0.011118:0.010434:0.005063:0.013906:0.004738:0.005063:0.012657:0.005073:0.011203:0.005148:0.011682:0.005063:0.015719:0.004738:0.004738
et al:@0.690677:0.405325:0.727760:0.405325:0.727760:0.391320:0.690677:0.391320:0.011118:0.005798:0.005063:0.011682:0.003421
. Global, regional, and:@0.727760:0.405325:0.915169:0.405325:0.915169:0.391320:0.727760:0.391320:0.004738:0.005063:0.014915:0.003421:0.011203:0.011665:0.011682:0.003421:0.004738:0.005063:0.005077:0.011118:0.011511:0.003421:0.011203:0.010434:0.011682:0.003421:0.004738:0.005063:0.011682:0.010434:0.011716
national incidence, prevalence, and years:@0.560589:0.419672:0.915147:0.419672:0.915147:0.405666:0.560589:0.405666:0.010434:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004864:0.003421:0.010434:0.011067:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118:0.004738:0.004859:0.011665:0.005080:0.011118:0.009476:0.011682:0.003421:0.011118:0.010434:0.011067:0.011118:0.004738:0.004863:0.011682:0.010434:0.011716:0.004863:0.009168:0.011118:0.011682:0.005148:0.006636
lived with disability for 310 diseases and in-:@0.560589:0.434018:0.915135:0.434018:0.915135:0.420013:0.560589:0.420013:0.003421:0.003421:0.009476:0.011118:0.011716:0.005525:0.014214:0.003421:0.005798:0.010434:0.005525:0.011716:0.003421:0.006636:0.011682:0.011665:0.003421:0.003421:0.003443:0.005798:0.009168:0.005525:0.005371:0.011203:0.005148:0.005516:0.009476:0.009476:0.009476:0.005525:0.011716:0.003421:0.006636:0.011118:0.011682:0.006636:0.011118:0.006636:0.005535:0.011682:0.010434:0.011716:0.005525:0.003421:0.010434:0.005679
juries, 1990-2015: a systematic analysis  for:@0.560589:0.448364:0.915152:0.448364:0.915152:0.434359:0.560589:0.434359:0.003472:0.010399:0.005148:0.003421:0.011118:0.006636:0.004738:0.007902:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004764:0.007902:0.011682:0.007902:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.007902:0.011682:0.010434:0.011682:0.003421:0.009168:0.006636:0.003421:0.006636:0.004738:0.003180:0.005371:0.011203:0.005148
the  Global Burden  of  Disease Study 2015.:@0.560589:0.462711:0.915135:0.462711:0.915135:0.448705:0.560589:0.448705:0.005798:0.010434:0.011118:0.004738:0.002622:0.014915:0.003421:0.011203:0.011665:0.011682:0.003421:0.007372:0.009818:0.010399:0.005047:0.011716:0.011118:0.010434:0.004738:0.002626:0.011203:0.005371:0.004738:0.002626:0.012726:0.003421:0.006636:0.011118:0.011682:0.006636:0.011118:0.007372:0.008518:0.005798:0.010399:0.011716:0.009168:0.007372:0.009476:0.009476:0.009476:0.009476:0.004738
Lancet.:@0.560589:0.477057:0.623327:0.477057:0.623327:0.463052:0.560589:0.463052:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.004738
 2016;388(10053):1545-1602.:@0.623310:0.477057:0.850080:0.477057:0.850080:0.463052:0.623310:0.463052:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009476:0.009476:0.009476:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
5.:@0.524242:0.491403:0.538459:0.491403:0.538459:0.477398:0.524242:0.477398:0.009479:0.004738
  STATS SA. Statistical release P0309.3 Mortality:@0.560589:0.491403:0.915172:0.491403:0.915172:0.477398:0.560589:0.477398:0.004738:-0.004738:0.008176:0.005559:0.010925:0.006944:0.008176:0.006038:0.008176:0.012315:0.004396:0.006038:0.008176:0.005456:0.011340:0.005456:0.003079:0.006294:0.005456:0.003079:0.010724:0.011340:0.003079:0.006038:0.004736:0.010776:0.003079:0.010776:0.011340:0.006294:0.010776:0.006038:0.009784:0.009134:0.009134:0.009134:0.009134:0.004396:0.009134:0.006038:0.015377:0.010861:0.004806:0.005456:0.011340:0.003079:0.003079:0.005456:0.009168
and causes of death in South Africa, 2015::@0.560589:0.505749:0.915155:0.505749:0.915155:0.491744:0.560589:0.491744:0.011340:0.010092:0.011374:0.007225:0.010724:0.011340:0.010057:0.006294:0.010776:0.006294:0.007225:0.010861:0.005029:0.007223:0.011374:0.010776:0.011340:0.005456:0.010092:0.007223:0.003079:0.010092:0.007225:0.008176:0.010861:0.010057:0.005456:0.010092:0.007225:0.012315:0.005029:0.004806:0.003079:0.010724:0.011340:0.004396:0.007225:0.009134:0.009134:0.009134:0.009134:0.004738
Findings from death notification. 2017. http://:@0.560589:0.520096:0.915162:0.520096:0.915162:0.506090:0.560589:0.506090:0.007954:0.003079:0.010092:0.011374:0.003079:0.010092:0.011169:0.006294:0.004079:0.005029:0.004734:0.010861:0.015702:0.004079:0.011374:0.010776:0.011340:0.005456:0.010092:0.004079:0.010092:0.010861:0.005456:0.003079:0.003994:0.003994:0.010724:0.011340:0.005456:0.003079:0.010861:0.010092:0.004396:0.004079:0.009134:0.009134:0.009134:0.009134:0.004396:0.004074:0.010092:0.005456:0.005456:0.011323:0.004396:0.007133:0.007475
www.statssa.gov.za/publications/P03093/:@0.560589:0.534442:0.891199:0.534442:0.891199:0.520437:0.560589:0.520437:0.013872:0.013872:0.013872:0.004396:0.006294:0.005456:0.011340:0.005456:0.006294:0.006294:0.011340:0.004396:0.011169:0.010861:0.009134:0.004396:0.006927:0.011340:0.007133:0.011323:0.010057:0.011323:0.003079:0.003079:0.010724:0.011340:0.005456:0.003079:0.010861:0.010092:0.006294:0.007133:0.009784:0.009134:0.009134:0.009134:0.009134:0.009134:0.007475
P030932015.pdf. Accessed January 2018.:@0.560589:0.548788:0.887196:0.548788:0.887196:0.534783:0.560589:0.534783:0.009784:0.009134:0.009134:0.009134:0.009134:0.009134:0.009134:0.009134:0.009134:0.009134:0.004396:0.011323:0.011374:0.005029:0.004396:0.004396:0.012315:0.010724:0.010724:0.010776:0.006294:0.006294:0.010776:0.011374:0.004396:0.007902:0.011340:0.010092:0.010057:0.011340:0.004806:0.008826:0.004396:0.009134:0.009134:0.009134:0.009134:0.004738
6.:@0.524242:0.563135:0.538456:0.563135:0.538456:0.549129:0.524242:0.549129:0.009476:0.004738
Cazap E, Magrath I, T Kingham P, :@0.560589:0.563135:0.826905:0.563135:0.826905:0.549129:0.560589:0.549129:0.013564:0.011340:0.006927:0.011340:0.011323:0.004345:0.008826:0.004396:0.004353:0.015377:0.011340:0.011169:0.004806:0.011340:0.005456:0.010092:0.004353:0.003523:0.004396:0.004353:0.006944:0.004351:0.009767:0.003079:0.010092:0.011169:0.010092:0.011340:0.015702:0.004351:0.007676:0.004396:0.004738
et al:@0.826510:0.563135:0.861854:0.563135:0.861854:0.549129:0.826510:0.549129:0.010776:0.005456:0.004351:0.011340:0.003421
. Struc-:@0.861512:0.563135:0.915160:0.563135:0.915160:0.549129:0.861512:0.549129:0.004396:0.004353:0.008176:0.005456:0.004806:0.010057:0.010724:0.005679
tural barriers  to diagnosis and treatment of:@0.560589:0.577481:0.915203:0.577481:0.915203:0.563476:0.560589:0.563476:0.005456:0.010057:0.004806:0.011340:0.003079:0.007321:0.011323:0.011340:0.004806:0.004806:0.003079:0.010776:0.004806:0.006294:0.004738:0.002574:0.005456:0.010861:0.007321:0.011374:0.003079:0.011340:0.011169:0.010092:0.010861:0.006294:0.003079:0.006294:0.007321:0.011340:0.010092:0.011374:0.007321:0.005456:0.004736:0.010776:0.011340:0.005456:0.015702:0.010776:0.010092:0.005456:0.007321:0.010861:0.005371
cancer in low- and middle-income coun-:@0.560589:0.591827:0.915179:0.591827:0.915179:0.577822:0.560589:0.577822:0.010724:0.011340:0.010092:0.010724:0.010776:0.004806:0.009527:0.003079:0.010092:0.009527:0.003079:0.010861:0.013872:0.005337:0.009527:0.011340:0.010092:0.011374:0.009527:0.015702:0.003079:0.011374:0.011374:0.003079:0.010776:0.005337:0.003079:0.010092:0.010724:0.010861:0.015702:0.010776:0.009527:0.010724:0.010861:0.010057:0.010092:0.005679
tries: the urgent need for scaling up. :@0.560589:0.606173:0.856114:0.606173:0.856114:0.592168:0.560589:0.592168:0.005456:0.004806:0.003079:0.010776:0.006294:0.004396:0.005337:0.005456:0.010092:0.010776:0.005337:0.010057:0.004820:0.011169:0.010776:0.010092:0.005456:0.005337:0.010092:0.010776:0.010776:0.011374:0.005337:0.005029:0.010861:0.004806:0.005337:0.006294:0.010724:0.011340:0.003079:0.003079:0.010092:0.011169:0.005337:0.010057:0.011323:0.004396:0.004738
Journal:@0.856713:0.606173:0.915193:0.606173:0.915193:0.592168:0.856713:0.592168:0.007902:0.010861:0.010057:0.004806:0.010092:0.011340:0.003421
of Clinical Oncology.:@0.560589:0.620520:0.728177:0.620520:0.728177:0.606514:0.560589:0.606514:0.010861:0.005029:0.004396:0.013564:0.003079:0.003079:0.010092:0.003079:0.010724:0.011340:0.003079:0.004396:0.014522:0.010092:0.010724:0.010861:0.003079:0.010861:0.011169:0.008826:0.004738
 2016; 34:1,14-19.:@0.727835:0.620520:0.860360:0.620520:0.860360:0.606514:0.727835:0.606514:0.004396:0.009134:0.009134:0.009134:0.009134:0.004396:0.004396:0.009134:0.009134:0.004396:0.009134:0.004396:0.009134:0.009134:0.005337:0.009134:0.009134:0.004738
7.:@0.524242:0.634866:0.538456:0.634866:0.538456:0.620861:0.524242:0.620861:0.009476:0.004738
  Carey P, Fudzulani R, Scholfield, :@0.560589:0.634866:0.834186:0.634866:0.834186:0.620861:0.560589:0.620861:0.004738:-0.004738:0.013906:0.011682:0.005080:0.011118:0.009168:0.007259:0.008017:0.004738:0.007256:0.008296:0.010399:0.011716:0.007269:0.010399:0.003421:0.011682:0.010434:0.003421:0.007257:0.010382:0.004738:0.007256:0.008518:0.011067:0.010434:0.011203:0.003421:0.004165:0.004165:0.011118:0.003421:0.011716:0.004738:0.004738
et al:@0.836704:0.634866:0.875978:0.634866:0.875978:0.620861:0.836704:0.620861:0.011118:0.005798:0.007254:0.011682:0.003421
. Re-:@0.875978:0.634866:0.915150:0.634866:0.915150:0.620861:0.875978:0.620861:0.004738:0.007256:0.010382:0.011118:0.005679
mote and rapid pathological diagnosis in:@0.560589:0.649212:0.915150:0.649212:0.915150:0.635207:0.560589:0.635207:0.016044:0.011203:0.005798:0.011118:0.007172:0.011682:0.010434:0.011716:0.007184:0.005148:0.011682:0.011665:0.003421:0.011716:0.007184:0.011665:0.011682:0.005798:0.010434:0.011203:0.003421:0.011203:0.011511:0.003421:0.011067:0.011682:0.003421:0.007184:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.003421:0.006636:0.007184:0.003421:0.010434
a resource challenged unit. :@0.560589:0.663559:0.801223:0.663559:0.801223:0.649553:0.560589:0.649553:0.011682:0.007286:0.005078:0.011118:0.006636:0.011203:0.010399:0.005024:0.011067:0.011118:0.007286:0.011067:0.010434:0.011682:0.003421:0.003421:0.011118:0.010434:0.011511:0.011118:0.011716:0.007286:0.010399:0.010434:0.003421:0.005798:0.004738:0.004738
J Clin Pathol:@0.803772:0.663559:0.910434:0.663559:0.910434:0.649553:0.803772:0.649553:0.008244:0.007286:0.013906:0.003421:0.003421:0.010434:0.007286:0.010126:0.011682:0.005798:0.010434:0.011203:0.003421
.:@0.910434:0.663559:0.915172:0.663559:0.915172:0.649553:0.910434:0.649553:0.004738
2014;Jun;67(6):540-3.:@0.560589:0.677905:0.731153:0.677905:0.731153:0.663900:0.560589:0.663900:0.009476:0.009476:0.009476:0.009476:0.004738:0.008244:0.010399:0.010434:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.004738
8.:@0.524242:0.692251:0.538456:0.692251:0.538456:0.678246:0.524242:0.678246:0.009476:0.004738
  Ngoya P, Muhogora W, Pitcher R. Defining:@0.560589:0.692251:0.915155:0.692251:0.915155:0.678246:0.560589:0.678246:0.004738:-0.004738:0.012657:0.011511:0.011203:0.009168:0.011682:0.006448:0.008019:0.004738:0.006460:0.015719:0.010399:0.010434:0.011203:0.011511:0.011203:0.005148:0.011682:0.006450:0.014607:0.004738:0.006460:0.010126:0.003421:0.005798:0.011067:0.010434:0.011118:0.005148:0.006459:0.010382:0.004738:0.006460:0.012726:0.011118:0.004165:0.004165:0.010434:0.003421:0.010434:0.011511
the diagnostic divide: an analysis of regis-:@0.560571:0.706598:0.915138:0.706598:0.915138:0.692592:0.560571:0.692592:0.005798:0.010434:0.011118:0.006575:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.005798:0.003421:0.011067:0.006585:0.011716:0.003421:0.009476:0.003421:0.011716:0.011118:0.004738:0.006585:0.011682:0.010434:0.006585:0.011682:0.010434:0.011682:0.003421:0.009168:0.006636:0.003435:0.006636:0.006585:0.011203:0.005371:0.006577:0.005078:0.011118:0.011511:0.003421:0.006636:0.005679
tered radiological equipment resources in:@0.560571:0.720944:0.915112:0.720944:0.915112:0.706939:0.560571:0.706939:0.005798:0.011118:0.005073:0.011118:0.011716:0.006756:0.005148:0.011682:0.011716:0.003421:0.011203:0.003421:0.011203:0.011511:0.003421:0.011067:0.011682:0.003421:0.006756:0.011118:0.011665:0.010399:0.003421:0.011665:0.016044:0.011118:0.010434:0.005798:0.006756:0.005078:0.011118:0.006636:0.011203:0.010399:0.005022:0.011067:0.011118:0.006636:0.006756:0.003421:0.010434
a low-income African country. :@0.560571:0.735290:0.817737:0.735290:0.817737:0.721285:0.560571:0.721285:0.011682:0.005080:0.003421:0.011203:0.014214:0.005679:0.003421:0.010434:0.011067:0.011203:0.016044:0.011118:0.005063:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.010434:0.005065:0.011067:0.011203:0.010399:0.010434:0.005798:0.005148:0.009168:0.004738:0.004738
Pan African:@0.818043:0.735290:0.915131:0.735290:0.915131:0.721285:0.818043:0.721285:0.010126:0.011682:0.010434:0.005066:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.010434
Medical Journal:@0.560571:0.749636:0.693985:0.749636:0.693985:0.735631:0.560571:0.735631:0.015719:0.011118:0.011716:0.003421:0.011067:0.011682:0.003421:0.004738:0.008244:0.011203:0.010399:0.005148:0.010434:0.011682:0.003421
. 2016;25:99.:@0.693985:0.749636:0.793482:0.749636:0.793482:0.735631:0.693985:0.735631:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738
9.:@0.524225:0.763983:0.538438:0.763983:0.538438:0.749977:0.524225:0.749977:0.009476:0.004738
  Meara J, Hagander L, Leather A, :@0.560589:0.763983:0.837804:0.763983:0.837804:0.749977:0.560589:0.749977:0.004738:-0.004738:0.015719:0.011118:0.011682:0.005148:0.011682:0.005183:0.008244:0.004738:0.005191:0.011682:0.011682:0.011511:0.011682:0.010434:0.011716:0.011118:0.005148:0.005188:0.007902:0.004738:0.005191:0.007902:0.011118:0.011682:0.005798:0.010434:0.011109:0.005148:0.005191:0.012657:0.004738:0.004738
et al:@0.838261:0.763983:0.875471:0.763983:0.875471:0.749977:0.838261:0.749977:0.011118:0.005798:0.005191:0.011682:0.003421
. Sur-:@0.875471:0.763983:0.915145:0.763983:0.915145:0.749977:0.875471:0.749977:0.004738:0.005191:0.008518:0.010399:0.005148:0.005679
gery and global health: a Lancet Commis-:@0.560589:0.778329:0.915157:0.778329:0.915157:0.764324:0.560589:0.764324:0.011511:0.011118:0.005148:0.009168:0.005102:0.011682:0.010434:0.011716:0.005114:0.011511:0.003421:0.011203:0.011665:0.011682:0.003421:0.005114:0.010434:0.011118:0.011682:0.003421:0.005798:0.010434:0.004738:0.005101:0.011682:0.005114:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.005101:0.013906:0.011203:0.016044:0.016044:0.003421:0.006636:0.005679
sion. :@0.560589:0.792675:0.601759:0.792675:0.601759:0.778670:0.560589:0.778670:0.006636:0.003421:0.011203:0.010434:0.004738:0.004738
The Lancet. :@0.601759:0.792675:0.702811:0.792675:0.702811:0.778670:0.601759:0.778670:0.007286:0.010434:0.011118:0.004738:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.004738:0.004738
2014;383(9911):12-13.:@0.702777:0.792675:0.877430:0.792675:0.877430:0.778670:0.702777:0.778670:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009476:0.009476:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
10.   Biccard B, Madiba T, Kluyt H. Perioperative:@0.524242:0.807022:0.915157:0.807022:0.915157:0.793016:0.524242:0.793016:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.009818:0.003421:0.011067:0.011067:0.011682:0.005046:0.011716:0.005713:0.009818:0.004738:0.005713:0.015719:0.011682:0.011716:0.003421:0.011665:0.011682:0.005713:0.005537:0.004738:0.005713:0.010109:0.003421:0.010399:0.009168:0.005798:0.005713:0.011682:0.004738:0.005713:0.010126:0.011118:0.005148:0.003421:0.011203:0.011665:0.011118:0.005148:0.011682:0.005798:0.003421:0.009476:-0.602972
patient  outcomes  in the  African  Surgical:@0.560589:0.821368:0.915152:0.821368:0.915152:0.807363:0.560589:0.807363:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.004738:0.004268:0.011203:0.010399:0.005798:0.011067:0.011203:0.016044:0.011118:0.006636:0.004738:0.004257:0.003421:0.010434:0.009014:0.005798:0.010434:0.011118:0.004738:0.004261:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.010434:0.004738:0.004262:0.008518:0.010399:0.005160:0.011511:0.003421:0.011067:0.011682:0.003421
Outcomes Study: a 7-day prospective ob-:@0.560589:0.835714:0.915140:0.835714:0.915140:0.821709:0.560589:0.821709:0.014864:0.010399:0.005798:0.011067:0.011203:0.016044:0.011118:0.006636:0.006175:0.008518:0.005798:0.010399:0.011716:0.009168:0.004738:0.006175:0.011682:0.006175:0.009476:0.005679:0.011716:0.011682:0.009168:0.006187:0.011665:0.005080:0.011203:0.006636:0.011665:0.011118:0.011067:0.005798:0.003421:0.009476:0.011118:0.006175:0.011203:0.011665:0.005679
servational cohort study. :@0.560589:0.850060:0.771367:0.850060:0.771367:0.836055:0.560589:0.836055:0.006636:0.011118:0.005148:0.009476:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.006363:0.011067:0.011203:0.010434:0.011203:0.005148:0.005798:0.006347:0.006636:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
The Lancet:@0.772992:0.850060:0.866185:0.850060:0.866185:0.836055:0.772992:0.836055:0.007286:0.010434:0.011118:0.006354:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798
. Pub-:@0.866185:0.850060:0.915155:0.850060:0.915155:0.836055:0.866185:0.836055:0.004738:0.006363:0.010126:0.010399:0.011665:0.005679
lished online Jan 2018.:@0.560589:0.864407:0.744580:0.864407:0.744580:0.850402:0.560589:0.850402:0.003421:0.003421:0.006636:0.010434:0.011118:0.011716:0.004738:0.011203:0.010434:0.003421:0.003421:0.010434:0.011118:0.004738:0.008244:0.011682:0.010434:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
11.   Abdel-Wahab M, Bourque JM, Pynda Y,:@0.524242:0.878753:0.915140:0.878753:0.915140:0.864748:0.524242:0.864748:0.009479:0.009479:0.004738:0.012650:0.004738:-0.004738:0.012828:0.011836:0.011888:0.011289:0.003592:0.005850:0.015736:0.011853:0.010605:0.011853:0.011836:0.009442:0.015890:0.004909:0.009442:0.009989:0.011374:0.010570:0.005183:0.011836:0.010570:0.011289:0.009442:0.008415:0.015890:0.004909:0.009442:0.010297:0.009339:0.010605:0.011888:0.011853:0.009442:0.008633:-0.713672
et al:@0.560589:0.893099:0.600801:0.893099:0.600801:0.879094:0.560589:0.879094:0.011289:0.005969:0.007680:0.011853:0.003421
. Status of radiotherapy resources in:@0.600972:0.893099:0.915143:0.893099:0.915143:0.879094:0.600972:0.879094:0.004909:0.007680:0.008689:0.005969:0.011853:0.005969:0.010570:0.006808:0.007680:0.011374:0.005542:0.007680:0.005319:0.011853:0.011888:0.003592:0.011374:0.005969:0.010605:0.011289:0.005319:0.011853:0.011836:0.009339:0.007680:0.005249:0.011289:0.006808:0.011374:0.010570:0.005200:0.011238:0.011289:0.006808:0.007680:0.003592:0.010434
Africa: an International Atomic Energy:@0.560589:0.907446:0.915155:0.907446:0.915155:0.893440:0.560589:0.893440:0.012828:0.005542:0.005319:0.003592:0.011238:0.011853:0.004909:0.012794:0.011853:0.010605:0.012794:0.004037:0.010605:0.005969:0.011289:0.005675:0.010605:0.011853:0.005969:0.003592:0.011374:0.010605:0.011853:0.003592:0.012794:0.012828:0.005969:0.011374:0.016215:0.003592:0.011238:0.012794:0.009339:0.010605:0.011289:0.005333:0.011682:0.009168
Agency analysis. :@0.560589:0.921792:0.710389:0.921792:0.710389:0.907787:0.560589:0.907787:0.012828:0.011682:0.011289:0.010605:0.011238:0.009339:0.008723:0.011853:0.010605:0.011853:0.003592:0.009339:0.006808:0.003592:0.006808:0.004909:0.004738
Lancet Oncol:@0.714374:0.921792:0.833797:0.921792:0.833797:0.907787:0.714374:0.907787:0.008073:0.011853:0.010605:0.011238:0.011289:0.005969:0.008723:0.015035:0.010605:0.011238:0.011374:0.003421
. 2013;14::@0.833968:0.921792:0.915128:0.921792:0.915128:0.907787:0.833968:0.907787:0.004909:0.008723:0.009647:0.009647:0.009647:0.009647:0.004909:0.009647:0.009647:0.004738
e168-175.:@0.560589:0.936138:0.640346:0.936138:0.640346:0.922133:0.560589:0.922133:0.011289:0.009647:0.009647:0.009647:0.005850:0.009647:0.009647:0.009647:0.004738